Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: A phase II study

  1. Gonzalez, E.E.
  2. Villanueva, N.
  3. Fra, J.
  4. Berros, J.P.
  5. Jimenez, P.
  6. Luque, M.
  7. Muñiz, I.
  8. Blay, P.
  9. Fernandez, Y.
  10. Vieitez, J.M.
  11. Muriel, C.
  12. Sanmamed, M.
  13. Coto, P.P.
  14. Izquierdo, M.
  15. Estrada, E.
  16. Lacave, A.J.
Revista:
Investigational New Drugs

ISSN: 0167-6997 1573-0646

Any de publicació: 2011

Volum: 29

Número: 6

Pàgines: 1459-1464

Tipus: Article

DOI: 10.1007/S10637-010-9442-2 GOOGLE SCHOLAR

Objectius de Desenvolupament Sostenible